| CYSB2400051 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-02-29 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2400052 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-02-29 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2400049 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-02-29 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2400050 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-02-29 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2400023 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-01-23 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CXSS2300100 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | New Drug Application | 2023-12-19 | | Wuhan Institute of Biological Products Co Ltd | | | view |
| JYSB2300141 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2023-08-18 | | | | | view |
| CYSB2300140 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2023-07-22 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2300080 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2023-04-11 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2300050 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | Supplementary Application | 2023-02-23 | | | | | view |
| CYSB2300024 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2023-01-31 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CYSB2200205 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | Supplementary Application | 2022-08-19 | | | | | view |
| CYSB2200156 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | Supplementary Application | 2022-06-16 | | | | | view |
| CYSB2200089 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | | | | view |
| CYSB2200090 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | | | | view |
| CYSB2200086 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | | | | view |
| CYSB2200087 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | | | | view |
| CYSB2200085 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | | | | view |
| CYSB2200048 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-02-16 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2200049 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-02-16 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
